Walleye Trading
NVAX icon

Walleye Trading’s Novavax NVAX Stock Holding History

Walleye Trading’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.35M Sell
165,700
-205,600
-55% -$1.86M ﹤0.01% 1953
2025
Q4 		$2.5M Sell
371,300
-46,700
-11% -$352K ﹤0.01% 1757
2025
Q3 		$3.62M Sell
418,000
-7,900
-2% -$61.5K 0.01% 1420
2025
Q2 		$2.68M Buy
425,900
+200,300
+89% +$1.33M ﹤0.01% 1558
2025
Q1 		$1.45M Sell
225,600
-9,600
-4% -$79.4K ﹤0.01% 1837
2024
Q4 		$1.89M Buy
235,200
+35,400
+18% +$341K ﹤0.01% 1726
2024
Q3 		$2.52M Sell
199,800
-114,600
-36% -$1.48M 0.01% 1531
2024
Q2 		$3.98M Buy
314,400
+6,000
+2% +$60.4K 0.01% 1182
2024
Q1 		$1.47M Buy
308,400
+44,300
+17% +$205K ﹤0.01% 1930
2023
Q4 		$1.27M Sell
264,100
-111,400
-30% -$682K ﹤0.01% 2273
2023
Q3 		$2.72M Buy
375,500
+4,700
+1% +$37.6K 0.01% 1551
2023
Q2 		$2.76M Buy
370,800
+330,100
+811% +$2.6M 0.01% 1410
2023
Q1 		$282K Sell
40,700
-19,500
-32% -$179K ﹤0.01% 3268
2022
Q4 		$619K Sell
60,200
-43,600
-42% -$769K ﹤0.01% 2636
2022
Q3 		$1.89M Buy
103,800
+72,100
+227% +$3.12M 0.01% 1731
2022
Q2 		$1.63M Buy
31,700
+500
+2% +$25.9K 0.01% 1846
2022
Q1 		$2.3M Buy
31,200
+20,200
+184% +$1.8M 0.01% 1557
2021
Q4 		$1.57M Sell
11,000
-29,600
-73% -$5.09M 0.01% 1838
2021
Q3 		$8.42M Sell
40,600
-15,100
-27% -$3.33M 0.03% 631
2021
Q2 		$11.8M Buy
55,700
+55,500
+27,750% +$10.2M 0.05% 375
2021
Q1 		$36K Sell
200
-1,200
-86% -$239K ﹤0.01% 4418
2020
Q4 		$156K Sell
1,400
-1,200
-46% -$128K ﹤0.01% 3682
2020
Q3 		$282K Buy
2,600
+2,300
+767% +$280K ﹤0.01% 2711
2020
Q2 		$25K Buy
+300
New +$11.5K ﹤0.01% 3951

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Walleye Trading's NVAX Position: Q1 2026 in Review

Walleye Trading reduced its Novavax (NVAX) stake by 77% in Q1 2026, selling an estimated $1.2M and leaving 40,148 shares worth $327K. The position accounts for ﹤0.01% of the portfolio, ranked #2834.

Walleye Trading first reported a position in NVAX in Q2 2015 and has held it in 16 quarters since. The position peaked at $1.16M in Q4 2025. 257 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

  • Walleye Trading held 40,148 shares of Novavax worth $327K as of Q1 2026.
  • Walleye Trading sold 132,532 Novavax shares in Q1 2026, an estimated $1.2M.
  • Novavax made up ﹤0.01% of Walleye Trading's portfolio in Q1 2026, its #2834 holding.
  • Walleye Trading first reported a position in Novavax in Q2 2015 and has held it in 16 quarters since.
  • Walleye Trading's Novavax position peaked at $1.16M in Q4 2025.
  • 257 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.